Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Heska Corp (HSKA) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Heska Corp. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1038133.
Total stock buying since 2014: $1,184,907.
Total stock sales since 2014: $50,566,981.
Total stock option exercises since 2014: $14,159,791.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 3,440 | $205,092 | 663 | $97,041 | 67,500 | $2,129,153 |
| 2021 | 2,000 | $352,000 | 11,000 | $2,726,800 | 36,908 | $610,600 |
| 2020 | 0 | $0 | 84,527 | $8,837,201 | 39,284 | $1,594,493 |
| 2019 | 1,000 | $73,790 | 30,000 | $2,879,920 | 120,667 | $2,135,618 |
| 2018 | 0 | $0 | 110,013 | $11,272,839 | 95,098 | $2,353,107 |
| 2017 | 1,000 | $90,000 | 83,289 | $7,788,466 | 69,145 | $1,288,826 |
| 2016 | 2,750 | $149,508 | 236,830 | $10,364,772 | 149,712 | $2,005,004 |
| 2015 | 500 | $14,525 | 173,235 | $5,627,542 | 169,376 | $1,859,799 |
| 2014 | 21,428 | $299,992 | 69,663 | $972,400 | 23,699 | $183,191 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-11-28 | Mcmahon John (VP, Chief Financial Officer) | Sale | 1,999 | 65.65 | 131,228 |
| 2016-11-28 | Mcmahon John (VP, Chief Financial Officer) | Option Ex | 1,999 | 34.08 | 68,115 |
| 2016-11-28 | Gordon G Irwin (Director) | Sale | 1,070 | 65.26 | 69,828 |
| 2016-11-25 | Larson Sharon J. (Director) | Buy | 1,750 | 66.87 | 117,018 |
| 2016-11-25 | Gordon G Irwin (Director) | Sale | 1,860 | 66.40 | 123,504 |
| 2016-11-22 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Sale | 5,000 | 64.85 | 324,260 |
| 2016-11-22 | Lippincott Rod (EVP, Comp. Animal Health Sales) | Option Ex | 5,000 | 12.74 | 63,724 |
| 2016-11-15 | Mcginley Michael J (Pres., Biologic. & Pharm.) | Option Ex | 1 | 17.17 | 17 |
| 2016-11-15 | Napolitano Jason A (COO, Chief Strategist and Sec.) | Option Ex | 9,000 | 17.17 | 154,530 |
| 2016-11-11 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Option Ex | 96,016 | 13.51 | 1,297,464 |
| 2016-11-10 | Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) | Option Ex | 6,000 | 17.17 | 103,020 |
| 2016-11-07 | Asakowicz Steve (EVP, Comp. Animal Health Sales) | Sale | 5,000 | 61.00 | 305,000 |
| 2016-11-07 | Asakowicz Steve (EVP, Comp. Animal Health Sales) | Option Ex | 5,000 | 7.36 | 36,800 |
| 2016-11-07 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Sale | 9,998 | 59.96 | 599,520 |
| 2016-09-01 | Napolitano Jason A (COO, CFO, EVP and Secretary) | Sale | 5,000 | 52.54 | 262,700 |
| 2016-08-29 | Wilson Kevin S. (CEO and President) | Sale | 13,668 | 51.87 | 708,918 |
| 2016-08-26 | Wilson Kevin S. (CEO and President) | Sale | 6,332 | 51.60 | 326,731 |
| 2016-08-24 | Mcmahon John (VP, Fin. Oper. & Controller) | Sale | 137 | 51.30 | 7,028 |
| 2016-08-09 | Asakowicz Steve (EVP, Comp. Animal Health Sales) | Sale | 4,698 | 52.55 | 246,865 |
| 2016-08-09 | Asakowicz Steve (EVP, Comp. Animal Health Sales) | Option Ex | 4,698 | 8.35 | 39,228 |
| 2016-08-03 | Wilson Kevin S. (CEO and President) | Sale | 30,720 | 47.34 | 1,454,376 |
| 2016-08-02 | Wilson Kevin S. (CEO and President) | Sale | 16 | 43.95 | 703 |
| 2016-07-29 | Wilson Kevin S. (CEO and President) | Sale | 20 | 43.95 | 879 |
| 2016-07-20 | Wilson Kevin S. (CEO and President) | Sale | 3,779 | 44.02 | 166,362 |
| 2016-07-18 | Wilson Kevin S. (CEO and President) | Sale | 5,465 | 44.31 | 242,132 |
| 2016-07-08 | Wilson Kevin S. (CEO and President) | Sale | 10,000 | 42.37 | 423,670 |
| 2016-07-07 | Napolitano Jason A (COO, CFO, EVP and Secretary) | Sale | 20,000 | 41.00 | 820,000 |
| 2016-07-06 | Wilson Kevin S. (CEO and President) | Sale | 5,960 | 40.27 | 240,009 |
| 2016-07-01 | Wilson Kevin S. (CEO and President) | Sale | 14,040 | 38.94 | 546,661 |
| 2016-06-02 | Wilson Kevin S. (CEO and President) | Sale | 20,000 | 36.74 | 734,800 |
| 2016-05-12 | Wilson Kevin S. (CEO and President) | Sale | 5,000 | 38.50 | 192,500 |
| 2016-05-10 | Wilson Kevin S. (CEO and President) | Sale | 15,000 | 36.88 | 553,125 |
| 2016-05-10 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Sale | 5,998 | 36.50 | 218,927 |
| 2016-05-10 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Option Ex | 5,998 | 14.22 | 85,291 |
| 2016-05-09 | Wilson Kevin S. (CEO and President) | Sale | 9,718 | 35.60 | 345,960 |
| 2016-05-05 | Wilson Kevin S. (CEO and President) | Sale | 1,282 | 35.67 | 45,727 |
| 2016-05-05 | Riley Sharon L. (Director) | Sale | 15,000 | 35.66 | 534,870 |
| 2016-05-05 | Riley Sharon L. (Director) | Option Ex | 15,000 | 10.16 | 152,415 |
| 2016-05-03 | Napolitano Jason A (COO, CFO, EVP and Secretary) | Sale | 5,000 | 35.75 | 178,750 |
| 2016-04-25 | Napolitano Jason A (COO, CFO, EVP and Secretary) | Option Ex | 1,000 | 4.40 | 4,400 |
| 2016-03-08 | Riley Sharon L. (Director) | Buy | 1,000 | 32.49 | 32,490 |
| 2016-01-27 | Napolitano Jason A (EVP, COO, CFO and Secretary) | Sale | 15,000 | 37.00 | 555,000 |
| 2015-12-29 | Napolitano Jason A (EVP, COO, CFO and Secretary) | Sale | 3,700 | 40.07 | 148,251 |
| 2015-12-22 | Napolitano Jason A (EVP, COO, CFO and Secretary) | Option Ex | 1,000 | 4.40 | 4,400 |
| 2015-12-15 | Napolitano Jason A (EVP, COO, CFO and Secretary) | Option Ex | 26,000 | 12.50 | 325,000 |
| 2015-12-03 | Wilson Kevin S. (CEO and President) | Sale | 4,400 | 35.50 | 156,200 |
| 2015-12-02 | Wilson Kevin S. (CEO and President) | Sale | 1,600 | 35.50 | 56,800 |
| 2015-12-01 | Wisnewski Nancy (EVP, Prod. Dev & Cust. Support) | Option Ex | 13,000 | 12.50 | 162,500 |
| 2015-11-25 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Sale | 958 | 33.62 | 32,210 |
| 2015-11-25 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Option Ex | 958 | 12.50 | 11,975 |
| 2015-11-24 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Sale | 1,427 | 33.35 | 47,594 |
| 2015-11-24 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Option Ex | 1,427 | 12.50 | 17,837 |
| 2015-11-18 | Wilson Kevin S. (CEO and President) | Sale | 6,000 | 35.00 | 210,000 |
| 2015-11-17 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Sale | 7,114 | 35.24 | 250,690 |
| 2015-11-17 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Option Ex | 7,114 | 12.50 | 88,925 |
| 2015-09-11 | Napolitano Jason A (Chief Financial Officer) | Sale | 1,699 | 33.51 | 56,933 |
| 2015-08-31 | Napolitano Jason A (Chief Financial Officer) | Sale | 4,998 | 33.62 | 168,007 |
| 2015-08-31 | Grieve Robert B (Executive Chair) | Sale | 9,798 | 33.75 | 330,682 |
| 2015-08-31 | Grieve Robert B (Executive Chair) | Option Ex | 9,798 | 12.50 | 122,475 |
| 2015-08-28 | Grieve Robert B (Executive Chair) | Sale | 1,300 | 33.95 | 44,135 |
| 2015-08-28 | Grieve Robert B (Executive Chair) | Option Ex | 1,300 | 12.50 | 16,250 |
| 2015-08-27 | Grieve Robert B (Executive Chair) | Sale | 3,604 | 33.83 | 121,930 |
| 2015-08-27 | Grieve Robert B (Executive Chair) | Option Ex | 3,604 | 12.50 | 45,050 |
| 2015-08-17 | Wilson Kevin S. (CEO and President) | Sale | 2,498 | 34.91 | 87,210 |
| 2015-08-17 | Grieve Robert B (Executive Chair) | Sale | 8,033 | 34.95 | 280,745 |
| 2015-08-17 | Grieve Robert B (Executive Chair) | Option Ex | 8,033 | 12.50 | 100,412 |
| 2015-08-14 | Wilson Kevin S. (CEO and President) | Sale | 200 | 34.94 | 6,988 |
| 2015-08-14 | Lippincott Rod (EVP, Companion Animal Sales) | Sale | 3,898 | 34.26 | 133,553 |
| 2015-08-14 | Lippincott Rod (EVP, Companion Animal Sales) | Option Ex | 3,898 | 7.86 | 30,618 |
| 2015-08-13 | Wilson Kevin S. (CEO and President) | Sale | 1,901 | 34.90 | 66,344 |
| 2015-08-11 | Wilson Kevin S. (CEO and President) | Sale | 2,763 | 35.19 | 97,229 |
| 2015-08-11 | Napolitano Jason A (Chief Financial Officer) | Sale | 3,301 | 35.58 | 117,442 |
| 2015-08-11 | Grieve Robert B (Executive Chair) | Sale | 1,106 | 35.00 | 38,714 |
| 2015-08-11 | Grieve Robert B (Executive Chair) | Option Ex | 1,106 | 12.50 | 13,825 |
| 2015-08-10 | Wilson Kevin S. (CEO and President) | Sale | 2,638 | 35.02 | 92,382 |
| 2015-08-10 | Grieve Robert B (Executive Chair) | Sale | 18,659 | 34.99 | 652,878 |
| 2015-08-10 | Grieve Robert B (Executive Chair) | Option Ex | 16,159 | 12.50 | 201,987 |
| 2015-08-04 | Grieve Robert B (Executive Chair) | Sale | 1,050 | 35.00 | 36,750 |
| 2015-07-30 | Napolitano Jason A (Chief Financial Officer) | Sale | 5,534 | 34.02 | 188,261 |
| 2015-07-13 | Grieve Robert B (Executive Chair) | Sale | 1,000 | 29.98 | 29,985 |
| 2015-06-08 | Wilson Kevin S. (CEO and President) | Sale | 11,810 | 30.16 | 356,236 |
| 2015-06-03 | Grieve Robert B (Executive Chair) | Sale | 3,699 | 31.32 | 115,845 |
| 2015-06-02 | Napolitano Jason A (Chief Financial Officer) | Sale | 2,464 | 31.51 | 77,640 |
| 2015-06-02 | Grieve Robert B (Executive Chair) | Sale | 13,301 | 31.37 | 417,239 |
| 2015-06-01 | Napolitano Jason A (Chief Financial Officer) | Sale | 2,335 | 31.81 | 74,276 |
| 2015-05-29 | Napolitano Jason A (Chief Financial Officer) | Sale | 5,201 | 32.47 | 168,855 |
| 2015-05-27 | Grieve Robert B (Executive Chair) | Sale | 1,500 | 31.00 | 46,500 |
| 2015-05-22 | Eyl Steven M. (EVP, Commercial Operations) | Sale | 2,336 | 30.07 | 70,231 |
| 2015-05-22 | Eyl Steven M. (EVP, Commercial Operations) | Option Ex | 2,336 | 7.81 | 18,244 |
| 2015-05-21 | Eyl Steven M. (EVP, Commercial Operations) | Sale | 3,645 | 30.27 | 110,337 |
| 2015-05-21 | Eyl Steven M. (EVP, Commercial Operations) | Option Ex | 3,645 | 8.26 | 30,107 |
| 2015-05-18 | Riley Sharon L. (Director) | Buy | 500 | 29.05 | 14,525 |
| 2015-05-15 | Sveen David E. (Director) | Option Ex | 7,224 | 9.39 | 67,833 |
| 2015-05-07 | Gordon G Irwin (Director) | Option Ex | 4,000 | 8.00 | 32,000 |
| 2015-04-24 | Grieve Robert B (Executive Chair) | Sale | 5,000 | 30.00 | 150,000 |
| 2015-04-22 | Grieve Robert B (Executive Chair) | Sale | 1,000 | 28.00 | 28,000 |
| 2015-04-13 | Grieve Robert B (Executive Chair) | Sale | 4,000 | 26.54 | 106,176 |
| 2015-03-09 | Wilson Kevin S. (CEO and President) | Sale | 10,000 | 25.38 | 253,780 |
| 2015-03-09 | Napolitano Jason A (Chief Financial Officer) | Sale | 5,765 | 26.02 | 149,988 |
| 2015-03-09 | Grieve Robert B (Executive Chair) | Sale | 2,000 | 25.26 | 50,526 |
| 2015-03-09 | Aylesworth William A (Director) | Option Ex | 4,571 | 11.00 | 50,281 |
| 2015-02-03 | Grieve Robert B (Executive Chair) | Option Ex | 28,203 | 10.33 | 291,280 |
| 2015-02-02 | Napolitano Jason A (Chief Financial Officer) | Option Ex | 19,500 | 8.80 | 171,600 |
| 2015-01-16 | Wisnewski Nancy (EVP, Prod. Dev. & Cust. Supp) | Option Ex | 6,500 | 8.80 | 57,200 |
| 2014-11-30 | Sveen David E. (Director) | Buy | 21,428 | 14.00 | 299,992 |
| 2014-11-30 | Wilson Kevin S. (CEO and President) | Sale | 28,928 | 14.00 | 404,992 |
| 2014-11-21 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Sale | 9,499 | 15.45 | 146,788 |
| 2014-11-21 | Mcginley Michael J (Presi, Biologic. & Pharm.) | Option Ex | 9,499 | 8.80 | 83,591 |
| 2014-11-21 | Grieve Robert B (Executive Chair) | Sale | 1,000 | 15.54 | 15,540 |
| 2014-11-20 | Grieve Robert B (Executive Chair) | Sale | 2,500 | 15.30 | 38,250 |
| 2014-11-19 | Grieve Robert B (Executive Chair) | Sale | 3,000 | 15.12 | 45,375 |
| 2014-11-03 | Aylesworth William A (Director) | Sale | 5,000 | 13.67 | 68,355 |
| 2014-11-03 | Aylesworth William A (Director) | Option Ex | 5,000 | 8.60 | 43,000 |
| 2014-08-25 | Grieve Robert B (Chief Executive Officer) | Sale | 1,000 | 13.40 | 13,400 |
| 2014-08-18 | Aylesworth William A (Director) | Sale | 1,600 | 13.55 | 21,680 |
| 2014-08-12 | Aylesworth William A (Director) | Option Ex | 5,000 | 4.60 | 23,000 |
| 2014-08-04 | Grieve Robert B (Executive Chair and Director) | Sale | 12,000 | 13.53 | 162,384 |
| 2014-07-07 | Aylesworth William A (Director) | Option Ex | 4,200 | 8.00 | 33,600 |
| 2014-06-05 | Grieve Robert B (Executive Chair and Director) | Sale | 936 | 10.68 | 9,991 |
| 2014-05-14 | Aylesworth William A (Director) | Sale | 4,200 | 10.87 | 45,645 |
Insider trading activities including stock purchases, stock sales, and option exercises of HSKA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Heska Corp (symbol HSKA, CIK number 1038133) see the Securities and Exchange Commission (SEC) website.